Robert Buckley - Dec 2, 2024 Form 4 Insider Report for NOVANTA INC (NOVT)

Role
Chief Financial Officer
Signature
/s/ John Burke, Attorney-in-Fact
Stock symbol
NOVT
Transactions as of
Dec 2, 2024
Transactions value $
-$314,515
Form type
4
Date filed
12/4/2024, 04:44 PM
Previous filing
Nov 8, 2024
Next filing
Dec 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NOVT Common Stock Options Exercise $28.8K +2.04K +1.69% $14.13 122K Dec 2, 2024 Direct F1
transaction NOVT Common Stock Sale -$28.5K -172 -0.14% $165.87 122K Dec 2, 2024 Direct F1, F2
transaction NOVT Common Stock Sale -$64.4K -386 -0.32% $166.84 122K Dec 2, 2024 Direct F1, F3
transaction NOVT Common Stock Sale -$96.7K -576 -0.47% $167.95 121K Dec 2, 2024 Direct F1, F4
transaction NOVT Common Stock Sale -$81.1K -480 -0.4% $169.02 121K Dec 2, 2024 Direct F1, F5
transaction NOVT Common Stock Sale -$72.6K -427 -0.35% $169.92 120K Dec 2, 2024 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NOVT Stock Option (Right to Buy) Options Exercise $0 -2.04K -12.4% $0.00 14.4K Dec 2, 2024 Common Stock 2.04K $14.13 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024.
F2 This transaction was executed in multiple trades ranging from $165.36 to $166.31. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades ranging from $166.49 to $167.27. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades ranging from $167.58 to $168.25. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades ranging from $168.61 to $169.36. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades ranging from $169.61 to $170.07. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 The Stock Options vested in three equal installments on March 30, 2017, March 30, 2018, and March 30, 2019.